Therapeutic Indications

Bazedoxifene is indicated for:

at least one of
Postmenopausal osteoporosis with pathological fracture

Postmenopausal osteoporosis
and additionally
Menopause present

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Oral

Contraindications

Active ingredient Bazedoxifene is contraindicated in the following cases:

No gender/age discrimination

at least one of
Thromboembolic disorder

Pulmonary embolism

Malignant neoplasm of corpus uteri

Malignant neoplasm of uterus, part unspecified

Other abnormal uterine and vaginal bleeding

Pregnancy

Lactation

Hepatic insufficiency